Dimethyltryptamine Screen, Serum/Plasma Test (9156SP)

Dimethyltryptamine Screen, Serum/Plasma Test (9156SP)

Analysis Code 9156SP 
Test Name Dimethyltryptamine Screen, Serum/Plasma 
Test Includes Dimethyltryptamine 
Compound Synonym(s) Component of Ayahuasca; DMT 
Purpose Exclusion Screen; This test is New York State approved. 
Category Hallucinogen 
Method(s) Gas Chromatography (GC) 
Specimen Requirements 5 mL Serum or Plasma 
Transport Temperature Refrigerated 
Specimen Container NMS Labs has no experimental or literature-based data regarding the choice of specific specimen collection containers for this test. 
Special Handling Promptly centrifuge and separate Serum or Plasma into a plastic screw capped vial using approved guidelines. 
Light Protection Required Not Required 
Stability Room Temperature: Undetermined
Refrigerated: Undetermined
Frozen (-20 °C): Undetermined 
*Rejection Criteria Polymer gel separation tube (SST or PST). 
Known Interference(s) Dimethyltryptamine [GC]: Phencyclidine, Pheniramine 
Day(s) Test Set-up / TAT [GC] Tuesday Thursday / 3 days 
Suggested CPT Code 80307 
**Minimum Volume 2.4 mL 
Reflex Testing
(when required, addl' fee may apply)
5503SP - Dimethyltryptamine Confirmation, Serum/Plasma 
Test Summary Sheet Generate  

You are viewing Dimethyltryptamine Screen, Serum/Plasma Test (9156SP)
*Rejection criteria pertain to clinical specimen submissions only.
**Stated minimum volume allows for a single analysis. Repeat analysis will not be performed.


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9